— Biomedical Engineering Senior Design Experience

Prerequisites & course information

This version has ended; see updated course, below. Course Description: Application of bioengineering theory and experimental analysis to a design project culminating in the design of a unique solution to a biomedical problem. Continues in BIM 110C . Learning Activities: Lecture/Discussion 2 hour(s), Project 6 hour(s). Enrollment Restriction(s): Restricted to senior Biomedical Engineering majors. Grade Mode: Letter. General Education: Science & Engineering (SE); Oral Skills (OL); Visual Literacy (VL). BIM 110B — Biomedical Engineering Senior Design Experience (3 units) Course Description: Application of bioengineering theory and experimental analysis to a design project culminating in the design of a unique solution to a biomedical problem. Continues in BIM 110C . Prerequisite(s): BIM 110A . Learning Activities: Lecture/Discussion 2 hour(s), Project 6 hour(s). Enrollment Restrictions: Restricted to senior Biomedical Engineering majors. Grade Mode: Letter. General Education: Science & Engineering (SE); Visual Literacy (VL). This course version is effective from, and including: Winter Quarter 2027. Learning Activities: Lecture/Discussion 2 hour(s), Project 6 hour(s). Enrollment Restriction(s): Restricted to senior Biomedical Engineering majors. Grade Mode: Letter. General Education: Science & Engineering (SE); Oral Skills (OL); Visual Literacy (VL). BIM 110B — Biomedical Engineering Senior Design Experience (3 units) Course Description: Application of bioengineering theory and experimental analysis to a design project culminating in the design of a unique solution to a biomedical problem. Continues in BIM 110C . Prerequisite(s): BIM 110A . Learning Activities: Lecture/Discussion 2 hour(s), Project 6 hour(s). Enrollment Restrictions: Restricted to senior Biomedical Engineering majors. Grade Mode: Letter. General Education: Science & Engineering (SE); Visual Literacy (VL). This course version is effective from, and including: Winter Quarter 2027.